Health Condition 1: I22- Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
Conditions
Interventions
Control Intervention1: NIL: NIL
Sponsors
Pragya Hangma Subba
Eligibility
Inclusion criteria
Inclusion criteria: Patients above 18 years of age have documented administration of at least two different oral DAPT after PCI with DES implantation.
Exclusion criteria
Exclusion criteria: 1. Patients with active bleeding or bleeding disorder 2. Patients with contraindications to antiplatelet therapy 3. Patients with ongoing long-term treatment with oral anticoagulants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is Net Adverse Clinical Events ( NACE ) within 3-6 months of percutaneous coronary intervention, which includes major adverse cardiac and cerebrovascular events (MACCE) plus major bleeding includes the composite of all-cause death, myocardial infarction, stent thrombosis, stroke, and target vessel revascularization.Timepoint: 3-6 months after percutaneous coronary intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints included each component of the primary endpoint. The incidence of the primary outcome of MACE observed when switching to an alternative oral P2Y12 inhibitor.Timepoint: 3-6 months | — |
Countries
India
Contacts
Public ContactPragya Hangma Subba
Jawaharlal Nehru Medical College Aligarh Muslim University Aligarh
Outcome results
None listed